<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01344928</url>
  </required_header>
  <id_info>
    <org_study_id>95/180/2010</org_study_id>
    <nct_id>NCT01344928</nct_id>
  </id_info>
  <brief_title>The Effects of Short-time High-intensity Interval Training on Tissue Glucose and Fat Metabolism in Healthy Subjects and Patients With Type 2 Diabetes</brief_title>
  <acronym>HITPET</acronym>
  <sponsors>
    <lead_sponsor>
      <agency>Turku University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>European Foundation for the Study of Diabetes</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ministry of Education and Culture, Finland</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Orion Farmos Research Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Academy of Finland</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Turku PET Centre</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Turku</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Verve Research, Oulu, Finland</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Helsinki University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Turku University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objectives of this study are to investigate the effects of short-time high-intensity
      interval training on tissue glucose and fat metabolism in healthy lean subjects and type 2
      diabetic patients using modern and noninvasive imaging methods positron emission tomography
      (PET), magnetic resonance imaging (MRI) and magnetic resonance spectroscopy (MRS).
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <number_of_arms>2</number_of_arms>
  <condition>Type 2 Diabetes Mellitus</condition>
  <condition>Healthy Volunteers</condition>
  <arm_group>
    <arm_group_label>HIT training</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Aerobic exercise training</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>HIT exercise intervention</intervention_name>
    <arm_group_label>HIT training</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Aerobic exercise intervention</intervention_name>
    <arm_group_label>Aerobic exercise training</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        The healthy patients

          1. Age 40-55

          2. BMI 18.5-30

          3. Fasting plasma glucose less than 6.1 mmol/l

          4. Normal glucose tolerance test (OGTT)

        The type 2 diabetic patients:

          1. Age-, sex-, and BMI-matched with the study subjects in the phase 1

          2. In a good treatment balance

          3. Glycated haemoglobin (HbA1c) less than 7.5 mmol/l

          4. Two hours glucose value in oral glucose tolerance test (OGTT) less than 10.0 mmol/l

        Exclusion Criteria:

        The healthy patients

          1. Blood pressure &gt; 140/90 mmHg

          2. Any chronic disease

          3. Any chronic medical defect or injury which hinder/interfere everyday life

          4. History of anorexia nervosa or bulimia

          5. History of rest or exercise-induced asthma

          6. Previous use of anabolic steroids, additives or any other substrates

          7. Smoking of tobacco, taking of snuffs, or use of narcotics.

          8. Significant use of alcohol

          9. Any other condition that in the opinion of the investigator could create a hazard to
             the subject safety, endanger the study procedures or interfere with the interpretation
             of study results

         10. Presence of any ferromagnetic objects that would make MR imaging contraindicated

         11. Current or history of regular and systematic exercise training

         12. VO2max &gt;40 ml/min/kg

        The type 2 diabetic patients:

          1. Any other chronic disease than diabetes

          2. Blood pressure &gt; 140/90 mmHg

          3. Any chronic medical defect or injury which hinder/interfere everyday life

          4. History of anorexia nervosa or bulimia

          5. History of rest or exercise-induced asthma

          6. Smoking of tobacco, taking of snuffs, or use of narcotics.

          7. Any other condition that in the opinion of the investigator could create a hazard to
             the subject safety, endanger the study procedures or interfere with the interpretation
             of study results

          8. Presence of any ferromagnetic objects that would make MRI imaging contraindicated

          9. Current or history of regular and systematic exercise training

         10. VO2max &gt;40 ml/ min/kg
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Turku PET Centre</name>
      <address>
        <city>Turku</city>
        <zip>20521</zip>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jarna C Hannukainen, PhD</last_name>
      <phone>+358-2-3131878</phone>
      <email>jarna.hannukainen@tyks.fi</email>
    </contact>
    <investigator>
      <last_name>Jarna C Hannukainen, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Kari K Kalliokoski, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Joonas J Eskelinen, BM</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Anna Savolainen, BM</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ilkka Heinonen, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Kirsi A Virtanen, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jukka Kemppainen, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Juhani Knuuti, Professor</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pirjo Nuutila, Professor</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jussi Pärkkä, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Virva Lepomäki, MSc</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Riitta Parkkola, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <verification_date>April 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 28, 2011</study_first_submitted>
  <study_first_submitted_qc>April 28, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 29, 2011</study_first_posted>
  <last_update_submitted>April 28, 2011</last_update_submitted>
  <last_update_submitted_qc>April 28, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 29, 2011</last_update_posted>
  <responsible_party>
    <organization>Jarna Hannukainen, Turku PET Centre</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

